IRMD - Iradimed Co

IRMD - Iradimed Co

https://www.iradimed.com

Hold Momentum: Bearish

Recent News

Powered by Alpha Vantage

IRADIMED CORPORATION to Hold Second Quarter of 2025 Financial Results Conference Call on August 1, 2025

GlobeNewswire • 1 month, 2 weeks ago • score: 0.47

ORLANDO, Fla., July 25, 2025 ( GLOBE NEWSWIRE ) -- IRADIMED CORPORATION ( NASDAQ: IRMD ) announced today that the Company will release its 2025 second quarter financial results before the market opens on Friday, August 1, 2025. Iradimed management will host a conference call the same day ...

IRADIMED CORPORATION to Hold Second Quarter of 2025 Financial Results Conference Call on August 1, 2025 - iRadimed ( NASDAQ:IRMD )

Benzinga • 1 month, 2 weeks ago • score: 0.45

ORLANDO, Fla., July 25, 2025 ( GLOBE NEWSWIRE ) -- IRADIMED CORPORATION IRMD announced today that the Company will release its 2025 second quarter financial results before the market opens on Friday, August 1, 2025. Iradimed management will host a conference call the same day beginning at 11:00 ...

New Strong Sell Stocks for June 12th

Zacks Commentary • 3 months ago

LYB, IRMD and SONY have been added to the Zacks Rank #5 (Strong Sell) List on June 12, 2025.

IRadimed ( IRMD ) Lags Q1 Earnings Estimates

Zacks Commentary • 4 months, 1 week ago • score: 0.11

iRadimed (IRMD) delivered earnings and revenue surprises of -2.33% and 0.26%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

CORRECTION -- IRADIMED CORPORATION to Hold First Quarter of 2025 Financial Results Conference Call on May 5, 2025

GlobeNewswire • 4 months, 2 weeks ago • score: 0.47

WINTER SPRINGS, Fla., April 28, 2025 ( GLOBE NEWSWIRE ) -- In a release issued under the same headline earlier today by IRADIMED CORPORATION ( NASDAQ: IRMD ) , please note that in the first paragraph the date of the earnings call should read "Monday, May 5, 2025" instead of "Friday, May 5, 2025".

IRADIMED CORPORATION To Participate at the 37th Annual Roth Conference

GlobeNewswire • 6 months ago • score: 0.56

WINTER SPRINGS, Fla., March 10, 2025 ( GLOBE NEWSWIRE ) -- IRADIMED CORPORATION ( the "Company" ) ( NASDAQ: IRMD ) today announced that it will participate in the 37th Annual Roth Conference.

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Range-Bound

As of 2025-09-10 (Snapshot)

IRADIMED CORPORATION develops, manufactures, markets and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories and services in the United States and internationally. The company is headquartered in Winter Springs, Florida.

52W High

$74.00

52W Low

$44.15

MA Status:

50D: Above 200D: Above

Beta (~1 neutral, <0.9 lower risk)

1.03

Valuation

Rich

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

44.71

Forward P/E (<15 better)

35.97

EV/EBITDA (<8 favorable)

35.07

EV/Revenue (<3 favorable)

11.11

P/S (TTM) (<3 favorable)

11.80

P/B (<3 favorable)

9.71

Ownership

Balanced

Source: Overview

Insiders (1–5% typical)

36.81%

Institutions (25–75% balanced)

59.30%

Shares Outstanding

12,720,000

Float

7,171,500

Dividend Yield (2–6% sweet spot)

0.01%

Ex‑Dividend Date

2025-08-18

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

77,635,000

Gross Profit (TTM)

59,750,000

EPS (TTM)

1.61

Profit Margin (>10% good)

0.27%

Operating Margin (TTM) (higher better)

0.33%

ROE (TTM) (>15% strong)

0.24%

EPS YoY (Quarterly) (>10% good)

0.18

Revenue YoY (Quarterly) (>8% good)

0.14

Momentum

Bearish momentum

Value

2.3208

Previous

2.4682

Trend

Falling

Signal Cross

No cross

As of

Sep. 05, 2025